2024-12-31-accounts

RePORT OVTME TRusfEES AND UIIAUDrrED FIIIANCIAL sfATEMEIITS FIX THE YEAR ENDED 31 DECEMBER 2024 29 Glbdredge Road BN214RU

coIKrEirfs OF THE FINANCIAL sfATEMEpirs FOR THE YEAR ENDED 31 DECEMBER 2024 TAR 1-14 Soclety InfonNth Indep￿d•￿t Ex•mln•V• Rwt st¥tement of fln•nd•l Actlvld B•l•rtc• She•t 5 to 11 12 to 13

Trustees, Annual Report for the period Period start date jDay 101 Period end date Month From 01 2024 31 2024 Section A Reference and administration details Charity name International Society of Hypertension Other names charity 15 known by ISH Registered charitable incorporated organisBtion ICIOI number 1204969. Formerly ISH was an unincorporated charity with registered number1122135. Registered charity number lif anyl Charity's prlncipal address 29 Gildredge Road Eastbourne East Sussex Postcode 8N214RU Names of the charitytrustees who manage the charity Narne of person lor body) entitled to appoint trustee lif any) Dates acted If not for whole year Trustee name Office lif any) George Stergiou (Greecel Secretary President 01.01.24- 21.09.24 21.09.24- 31.12.24 21.09.24- 31.12.24 Dagnovar Aristizabal Icolombial Hind Mamoun Beheiry Ahmed (Sudanl Cl8udio Borghi Iltalyl Fadi Charchar (Austral￿8> Myeong-chan Cho (South Koreal Débora Colombari (Brazill Hiroshi Itoh Ilapanl Erika lones (South Africa) Nadia Khan (Canada) Kazuomi Kario Ilapan 21.09.24- 31.12.24 01.01.24- 21.09.24 01.01.24- 21.09.24 01.01.24-31.12.24 Treasurer 21.09.24- 31.12.24 01.01.24-31.12.24 21.09.24- 31.12.24 01.01.24- 21.09.24 01.01.24- 21.09.24 21.09.24- 31.12.24 01.01.24-31.12.24 21.09.24-31.12.24 01.01.24- 21.09.24 Vice President Offi¢er at Large Officer at Large 10 Secretary 12 Tazeen lafar Isingaporel Yan Li Ichinal Dorairaj Prabhakaran Ilndial Cesar Romero IUSAI 14 01.01.24- 21.09.24 21.09.24- 31.12.24 01.01.24-31.12.24 15 Treasurer Ulrike Steckelings (Denmarkl Maciej Tomaszewski IUKI Bryan Willi8ms IUKI Immediate Past President President Immediate P8St President 01.01.24- 21.09.24 01.01.24-21.09.24 21.09.24- 31.12.24 TAR

Names and addro$se$ otadvlsers (Optlonal Informatlon) Type of advlsor Namo Addre88 Accountant Advants Chartered 29 Gildredge Road. Easts)oume. East Sussex, BN214RU, UK Accountsnts N8m• of chlef executhie or names of senlor staff MeM￿r$I0 tlonal Infomiatlon) NIA Sectior) B Structure, zovernciiice rid In[?ni< oement Descrfption of the ¢harltystrusts Type of governlng document leg. trusl Lleed, constitution) The current ISH Constitution was Ini￿allY accepted bysociety memb8rs on 26 September2022. However, itwas leg811y 8CCePted on 29 September 2023, when ISH vffjs officially registered as a Charitsble Incorporated Organisation ICIO) in England and Wales (registration number 12049691. Howthe charity is constituted leg. trust. association, company) The ISH is 8 registèred Ch8rit8ble IncorpOr￿ed Org8nisation ICIOI in Eng￿nd and Wales Ireostration number 12049691 registered on 29 September 2023. The Societywas previously an Unincorporated Charity IUCI registered under number 1122135. 80th the ISH entitie5- the UC and the CIO- operated concurrentty for a period. while new bank a¢¢ounts ¥ft￿ estsbil$hed, and systems were fully Implemented. Thetransferofallfunds and netassetsfromthe ISH Uctothe ISH ClOv￿S formalty completed on 23" December 2024. The Executive Committee of ISH concluded thattransitioningfrom an UC to CIO offered signfficant advantsges to the Society. The Most important b8nefits of the CIO structure to the ISH ar8: Separate Leg81 Pèrsonality. The CIO has its own legal Identity, allowing it to enter into contracts. own property. and conduct all business in the charltys name, ratherth8n in the names ofthe indiwdual Trustees. Twstee Protection {Llmtted Liability): Members and Trustees are generally protected from personal liabiiityfor 8ny debts or obligations incurred bythe charity. This is a critical improvement, as Trustees ofthe prv4ious UC were each and severally liable forthe debts of ISH. The Trustees of the old charty andthe CIO at the time of the transfer were the $8rn8 persons. Accordingly. for most pr8Ctical purposes th8 charity is continuing as before. Trustee selection method$ leg- <ippointe(J by. elected by) A callfor nominations is made to membership. Votes are ¢8St by members ata (Bienniall General Meeting or by an electronic b811ot. Those who are 8lect8d to membership of the ISH Councll forthe succeedingfour years become Trustees and arnfomalty 8ppoint8d 8t tho General Meetlng. Addttlonaigovernance Issues IOptlonallnfom￿onj You may ehoose to include additional information. ¥¥her8 relevant. about: Poli¢i85 and procedures adopted for the induction and tralnlng of In 2024. the ISH had an actNe membership of 1,905 experts from 110 countries Vltth 5 Corporate Member industy partners. ISH is a network committed to research and education for healthcare and allied professionals in the field of hypertension (high blood pressure) and on preventlng its consequences. and for TAR

trustees. The charity's organis8tional structure and any wider network with which the charity works. Relationship with any related parties. Trustees, consideration of major risks and the system and procedures to manage them. public information on hypertension. The daily management of the ISH is undertaken by an Executive Committee (the Executive) on behalf of the Council, comprising of Officers of the Society.. (President. Vice President, Secretary, Treasurer. Officer 8t Large and Immediate Past President). as well as an additional number of other elected Council Members as determined by the President. Committees and groupings have been established to assist with the management of the day-to-day activities of the Society. E8eh Committee is chaired by 8 member of the Council or by a Society member la list of all the committees can be found on the Society website). Altogether. the members of ISH Executive, the Council and all the members of ISH Committees constitute the ISH leadership. ISH administrative support for mernbership, communications, finance and other identified areas is maintained by external service provi(Jers Inotably Canica for membership and website management). The Society has one ISH employee with key responsibilities to support the Executive. Council, and the ISH leadership. The aim is for this dedicated full-time support to help the Society and volunteers and maintain continuity with activities. As the Society does not undertake fundraisingfrom the general public, the major risks to the continuation of the Society's programrne of educational activities are from 8 decrease in income from its industry partners, reduction in revenue from the Journal of Hypertension annual royalty fee and from its Biennial Scientific Meetings. Traditional and social media marketing and publicity is used to attract attendance to the ISH meetings. Amounts Spent to achieve the Society Objecis of education are limited by the income received (see under'Reserves Policy, in section E, below). Section C Objectives and activities Summaryofthe objects of the charity set out in its governing document To protect and promote the health of the public in particular by encouraging the advancement of scientific research and knowledge and of its application in all aspects of hypertension and associated cardiovascular diseases and to disseminate the useful results ol such research. Education: ISH prim8rily works with aff iliated societies in the region5 to forge stronger links with national and regional societies of hypertension and related bodies, to create wider awareness of the Society and importantly, to otfer support and help educate those in countries and regions most in need. Summary ofthe main activities undertaken forthe public benef it in relation to these objeGts linclude within this section the statutory declaratlon that trustees have had regard to the guidance issued by the Charity Commlssion on public benefit) ISH Regional Advisory Groups (RAGS) ensure that the Society is listening and responding io all members of its international constituency with a local flavour. Since October 2020, the map of ISH RAGS has been aligned with six World Health Organization (WHO) regions., there are RAGS in ISH as follows- 1. Alrica 2. Americas 3. Asia Pacific IAPACI 4. Europe Middle East and North Africa IMENAI 6. South and Central Asia ISACAI These groups are intended to provide comprehensive Society representation globally. to distil regional issues, encourage and enhance education and biomedical research in the fields of hypertension and associated cardiovascular diseases, support the emergence ol new regional TAR

and national societie$, vffjrk with existing Societies to undertakejolnt projects in the propagatlon of hypertension prevenlion and facilltate closerworkSng rela￿onshIpS and collaboration betsveen overlapplng regional gmups. BlennlalsCle￿fflc Meotlngg: The ISH Biennial Scientrfic Meetings are 8 plattorm for presentin8 completed and original scientific investigations and where delegates from all overthe wortd can meet and discuss pUb￿C health. clinical and population aspects ot hypertension r8S8arch. S88 section D tor further information on plans that are underwaytorthe 2026 and 2028 events. Now Invostlgator and Montorshlp andTrnlnlng cornn￿tt¢•$. It has been the mission of the ISH to encourage and support younger r&se8rch8rs, as the next generatlon of leaders in the global management of blood pressure. Through the continued development ofthe New Investigatorand Mentorship and Training Commtttees and the related New Investigator Network and mentorship webp8g8s (bt1p￿￿- and presence on Social media platforms (Facebook, X. Instsgram.YouTube and Linkedlnl. aswè118S thelaunch ofthe newCap8city Building Network at the end of 2023. the Society is extending ￿ reach to the new generation of researchers and doctors and future leaders in thefield. Womon in Hyporten$lon Rowr¢h Notwork" The ISH Women in Hypertension Rese8rch Network was established in 2016 to encourage. support and Inspire women in science and medicine in the field of hypertension and related cardiov8scuL8r diseases. Itaims to allow new avenues for communication, Collaboratlon and education. The key aims ate: To promote Tlvomen scientists and clinicians so thatthey can fulfil their career aspirations in th8field of hypertension 8nd rg18ttsd c8rdiovascuiar diseases. Promde a pLatfom for ne￿rkIn￿and mentoringto enable women hypertension researchers to maximlse career opportunfties. In partlcuiar. to reach outto those who do not have fonnal mentoring support. Recognise and promote the successès ol women in the hypertension communty. Involve all ISH members in promoiing equalopportunities for women in science and medicine based on merit. Affiliated Society Ènd Partnor Couaborationg: Increasingty effective links have been torged amongst national and regional societies of hypertension and high blood pressure research councils around the world vi8 our six Regional Advisory Groups. providing a piatformfor res88rch and intellectU81 exchange of ideas pertinent to scientific, economic and ethical aspects of cardiovascuLar preventlon and caffj. Th8 ISH RAGS additionally help to provide compr8hen8Ne Society representation globally. to resolve regional issues and encourage and enhance educatlon and biomedlcal research in the fields of hypertension and associated cardiovascular diseases. PubU¢ Awar•ness: World Hypertenslon Day(17May): Raised blood pressure is the biggest single contributing risk factorfor global death. Lots more needs to be done ty govemments. public health agencies and healthcare systems to counter the devaststlng and perpetual menace of hypertension-the silent killer. As a result of the r8pidlygrowing burden of disease associatèd with the global increase in hypertension the Society supports and encourages involvemenl in the annualworid Hypertension Day on 17 May bysociety members and affiliated regional and national societi8s (established by our partner organisation World Hypertension League). The theme otWHD in 2024 wa8'Measureyour blood prossure accuratoly, control It. Ilve longer, focusing on combatting low awareness rates worldwide. especially in iow-and middle- income areas. and accurate blood pressure measurement methods. As a part of commitm8nt to awareness of hi0) blood pressure. on 17 May 2024 the Society released a shortvideo to TAR

amplifythe mess8g8that 10 miuion d88ths 8veryy8ar acro88 the wortd could have been avolded sf high blood pressure had been detected and treated. Furthermore. th8 Soclety curatsd and shared a resource page highiightingtsntastlc global activities tsking place by m8ny of ourAffiliated Societies and members to markWHD and to act as a prompt for peopl8 to get Ihelr blood pressure checked rf not checked befoo. Plans We￿ oddltlonaltyadvanced In 2024 towrlte an ISH Patient-locvsed guidellne designed to empower and raikio patients. The Soclety has recognlsed thattherè is a need to create a iayfriendly document to better Communicato wlth patlents. explain what18 h8ppenlngto them and help them galn more control and understsnding regardlngthelr own blood pressure 8nd to lacilltate a transfer of power. The docUmentV￿lI outllne the optlmal standards and the minimum 8tsnd8rds th8t must be achieved. The docum8ntV•ryll be tallored to dlflerent levels of understgnding and made avaliabie In different iangu8g88 to faclltste adoptlon of the guldellne In the reglons. World Adhoron¢¢ Day Wlth p8rtner organlsatlons Ilncludlngthe Wortd H88rt F8dgratlonl. the ISH was Involved In 2024 In the establl8hment of a new Inltl8tfve- World Adherence Day. Thls Is an Inltl8tlv8 almed al ralslng 8w8ren988 about the Importanc8 of stlcklngto pre8¢rlbed he81thcare plans. The flrst World Adherence Dayvlll be obseMd on 27 March 2025. The day emphaslses tho signlflcance ol adherence to treatments. 88pec1811y for chronlc conditions, to Improve health outcomes and reduce ¢ompllcatlon8. The c8rnpaign oncour8g88 SndMdu818 to fouowthelr h•8lthcare provld8rs' recommendatlons, whether11 Involves mgdlc8tlon. Ufestyie ch8ngès. or malntalnlng a healthy routSne. The thema lor the day In 2025 wlll be"Don't Mlss a Moment.. highiightlng the Importance of Staylng on tr8ck wlth healthcare plans to protect meanlngfvi moments In Ufe. World Adh8r8nc8 Dayw88 publlc188d at the ISH2024 meetlng In the ISH Gattagena May M•••urom•ffl Month: Bulldlng on the success of the exlsttngwHD. thg ISH d8¥ignated thg entlre month of May a8 M8yMea8urement Month IMMMI In2017.Thealmwa8 to hl8thiightthe Importance ol meosurlngyour blood pre88ure IBPI and lo r81s8 8w8rene38 01 the dangers poged by elevated 8P and hyperten8lon. The target Is to Incre8se the number8 of p8rt1clpants aged 18+ who are reguL8rtygettlng thelr BP checked and to gbve people the too18 to understand how th18 Infomiatlon can contrlbutg to a person's knO￿ed89 about thelr IndMdu81 h88lth. MMM 8180 provldes dlet and Ilfesfyie 8¢fvice to those wlth 8P In the hypertenslvo r8nge 8nd to facllltste Improved follow up foi suffgrgr8. The ISH188d8r8hlp introduced a nèw model of gDV8rn8nce for the MMM Inltlatlve. whlch became effectlve from 10t January 2022. Thls Is because the expanslon of MMM was Incfeaslngiy consumlng leadershlp tlme and resources from the ISH. dlstractlng from the opportunltyto launch new Inltlattves. In thls newarrangement, MMM has become an Independent charity In England and Walès. However. th8 campaign contlnues to remaln strongly afflllated wlth the ISH as the foundlng p8rtner8nd successful MMM activltles took place once 88ain in m8ny parts of thoworid in 2024. Publlo Bon The Trustees have read theguidance issued bythe Ch8rbty Commission rel8tlngto publlc benefit and can ¢ontinn that the above 8¢tivities of the ISH benefit the public in general. Thls Is 8chieved by Improving the depth and spread of knowledge In the field of hypertension and cardiovascular dlsease. fosteringthe transL8tlon of novel clinlcal research and b8sic science into best cllnl¢al practice and increasing public awareness ol raised blood pressure. Upskllling practltloners improves healthcare forall those v￿th hypertension and oth8r related diseases. The charlty h8$ a track record of organlslng hlghquallty educatlonal courses. seminars, and meetings all overthe world. as V￿lI as providing expert faculty memb8rs to disseminate ihe Latest hypertenslon management guidelines. All these activities result in increased th0￿edge ty clinicians treating h ertension. There are no restrictions to thi8 TAR

overall beneflt In healthcare, as 8pe¢lfled in the Charity Commission guldgnce le.g., in temis of access, geography, membershlp, abilltyto pay etcl. Scction D Achievements and performance Summaryoftho maln a¢hlavement$ of the¢harltydurlng tho year Thesocletyhas a d8dlcat8d M8mber5hlpCommitteeto: 11} actlvely recruit new members 121 attract more geographically comp￿hen85ve membership and expand ISH'S global footprint of members 131 retain members and encourage 8CtNe participation 141 incre888 th8 number of paying members Members Sn 2024 Included tralnees, lunior and established scientists. clinicians. health care providers 8nd allied health care workers from across the gbbe, all wlth a common interest in hypertension research and patlent care. Atthe end of 2024. the Society had 1.905 members constiluting 1.202 Members (including 96 ISH Fellows. 14 DSstinguished, 59 Emerltus and 3 Honorary Fellows). 235 Trainees and 468 Assoclate Members. In addition, there were 5 Corporate Members {organisation- industry partners). The ten countries with the high8St number of membèrs included Japan, United States, Australia. China. Canada. India. UK. Nigeria. South Kor88 and South Africa. The ISH contlnued to workvAth a membershlp management org8nisatlon based in Argentina in 2024to improve the interface with ISH members. Worklng In Latin Amerlca is allowing the Society to Open our door8 to the large Spanish speaking hypertension communitythat had previously been untspped bythe ISH. The ISH leadership used this period of change as a great opportunity to set in motion a large membershlp restructure, designed to make membership more accessible for anyone with an interest in hypertension globally and to improve the overall membership experience. This restructure was Completed in 2024. Aehlevementg In 2024: Membershlp restructure plans were concluded and mede posslblewlth the assistance of an enthusiastic and dfiven Membership Commlttee chair and members. Changes agreed wlth the restructure included: A nèw and $impiifi8d set of membership cat8gori88 to Member. Traine8 8nd Asso¢late Member. Reduced fees and free memberships for m8mb8rs from parts ofthè world where fees can be a barrierto membership. Extensive promotion ofthe ￿ free membershlp catègories Ws80Cl8t8 Member end Traineel exlenslvely atvarlous events globally and on soclal medi8. A refreshed membership portal offering members access to training. resources. and other member beneflts. Previously all information had been accessible to members onlyvia th6 open ISH v￿b pages. As a result of our membership restructure and promoilon, w8 galned approximstely 800 newmemb8rs ofthèsocietyin 2024. TAR

Section D Achievements and performance A much-reLluced cost subscription to the ISH'S official Journal- the Journal ol Hypertension-continued to be offeredto members via the membership portal. ISH 2024 Scientific Meeting The 30th Scientific Meeting of the Intemational Society of Hypertension took p12ce from 19-22 Septernber 2024. in Cartagena de Indias, Colombia, with pre-event sessions held on 18 September. This event. held in conjunction with the Colombian Society of Cérdiology and Cardiovascular Surgery was supported by several key societies in the Tegion. The meeting hadthetheme'lmprovingthe Controlof Hypertensionworldwide. and was supported by approximately 1.500 participants from over 60 countries. including 160 speakers from over 35 countries. 472 abstracts weie submitted for the presentation of research and 285 abstracts presented in oral or poster presentation sessions. We also garnered support from 26 Sponsors forthe meeting. Multiple topics were covered at the meeting including eardiovas¢uLar risk tactofs, epidemiology of hypertension and metabolic disorders. blood pressure rneasurement. stroke. obesity and metabolic syndrome, hypertension rnediated organ darnage. res1Stant hypertension and diabetes. hypertension in pregnancy amongst others. Keynote sessions at the event discussed Al in healthcare. Genetics and genomics of sex determination and the Genetics of bloo(J pressure. Se55ions were devoted to furthering the ISH'S educational agenda. The programme included a variety ofjoint sessions with ISH partners such 8S the Latin American Society of Hypertension ILASHI. European Society of Hypertension IESHI, World Hypertension League IWHLI, Korean Hypertension Society IKSHI. American College ol Cardiology IACCI. There was a focus on the various regions of the world with sessions facilitated by three of the six ISH Regional Advisory Groups and dedicated slots in the programme lor women in hypertension research, mentorship. communication and new investigators. The ISH Capacity Building Network carried out successful activities at the evenl including two Speed Mentoring Lunchtime Sessions and a full day symposium on 18 September designed to help attendees communicate research eftectively, build their research networks and write a successful grant application. This event was attended by over 50 trainees. To add to this. the Society announced the 2024 ISH Collaboration Exchange Scholarship valued at USD 5,000. The aim of the ISH Collaboration Exchange Scholarship is to support the development of collaborative relationships andlor activities with someone they rnet at the 2024 ISH meeting. We have nowawarded two successful applicants with USDS,000 each. A record number of nominations were received in 2024 for the ISH Biennial awards, and winners were presented by the Society at the Cartagena 2024 meeting to honour members for their achievements. New awards developed forthe meeting included the ISH Emerging Leader Awards. With these awards, the ISH aims to provide a platform to promote the research of new investigators from each of the six ISH regions and increase inclusivity and representation of the ISH globally. At the close of the meeling. At ISH2024. Bryan Williams, ISH President 2022-2024, and Dagnovar Aristizabal. ISH2024 Chairman. signed the Qattag2na￿o01aration- a call to action to improve adherence to antihypertensive medications globally. The declaration highlights the establishment of a World Adherence Day, the first of which will take place on 27 March 2025. ISH 2026 Scientific Meeting Dubai was selected as Ihe destination for the ISH 2026 meeting in 2023. The co-host of this meetingwill be the Emirates Cardiac Society- Planning continued for this event in 2024, and the meeting was officially launched at the end otthe ISH Cartagena September meeting. TAR

Section D Achievements (incl performaiice ISH 2028 Sclentlflc Meetlng Atthg end of 2028. the ISH and European Socioty of Hypertenslon {ESHI leadershlp signed an agreement to hold a joint meeting in 2028 in Europe, in the tradltlon of several successfulloint meetings in the p8St. with proposals to hostthe meeting Invlted In 2025. In 2024, th8 ISH contlnued to p8rtn8rwith theJoum81 of Hypertension. 88 the official joumal of the Soclety. In addltion to prlmary papers from world-renowned experts. the Journal Ipublished bywolters Kluwerl contsins authorltatlve revlews that 8ummarlse and ev81uate the most signlflcant recent developments. Further 88lf-published items include ISH Hypertansion N8ws la magazlne produced approximately 3 times per yearl read bythe Socletys more than 7.000 Members and 8ubscribers and the ISHmonthtye-8ulletln. Papers publlshed in 2024 by the ISH or with ISH le8dershlp authorshipwere as follows. Inrtovatloni In blood pressure measurgment and reportlngtschnoiogy: Internalional Soclety of Hypertension po3ltlon paper endors￿ bythe World Hypertenglon League, European Soclety of Hyportanslon. Aslan Paclflc So¢lety of Hypertonglon, and Latln Amerlcan Soclety of Hyperten81on New blood pressure me8surement devices such as cuff-1988 wri8t monitors are likely to play an important rol8 in hyp8rt8n8ion diagnosis 8nd management In future- but several challenges remain before these newtechnologies can be introduced widely. accordingto 8 new position paper from the Internatlonal Soclety of Hypert8n8ion IISHI. A key Challenge Is that these new devices 8re not yet 88 8ccurate or reliabl8 as existing blood pressure monltors. The posltlon paper-wti￿￿ti£d in theJoum81 of Hypertension- looks at the evidence arouncl the accuracy. validation and clinlcal utllity of new kinds of blood pressure monltors and other innovations in hypertension. Prioritles to redu¢¢ thè burden of hypertenslon In Afr1￿ through ACHIEVE A paper published in the February 2024 issue of The Lancet Global He81th outlines the work ot the Accelerating African Control of Hypertension through Innovative Epidemlology and a Vibrant Ecosystem IACHIEVE) Inltlatlve. ISH President 2022-2024. Bryan Williams was one of the authors. The ISH Research and Education Committ88 commenced work In 2024 to develop multiple new position papers for publlcatlon in 202S and 2026. Authorship of the papers will Include r8pres8ntstion from Society leadership and membership in all regions whore possible, including 8 high p8rcents88 of woman and new investigators as collaborators. To add to this. the Societyworked with the Endocrlne Soclety on thelr new guideLin&s- to be released In 2025. The ISH. 88 8 respected body of expertise, is frequendy asked to endorse events and publications. It assesses these requests on the basis of criteri8 which are published on its website.The ISH Research. Sclence and Education Commlttee and Counciitypic8IIy consider sev8r81 such requests each month. A sample of the successful requests follows. Cllnlc81 Hyperten8lon Fellowship from the World Kldney Ac8demy. The f¢llow$hip 18 an onllng programme 81ructured as 3 moduL8$- 14 week8 88ch- almed at m?diGal doctors and h8alth¢are work•rs Involved In hypertension Gare, from anywhere In the world. Servier EVIDENTSummit- a 1-day event in the Middle E8St Re ion focused on TAR

Sectioii D Achievements and perforinaiice overcoming medication nonadherence and treatment inertia for patients with cardlometabollc dlse8$es. Th81 Hyp8rtenslon Camp org8nl8ed by the Thai Hypertenslon Soclety (THSI. Four one-dayworkshops took place- wlth 20 participants 8tt8ndlng each tlme to equlp 8ttend6esto become champions In hypertensSon care Inthe hospltatswhefe they w￿rk. Abbott's a.care congress h8ld In October commltted to advanclngtreatment adherence 8nd behgvioural science through research. evld8nc8-based practlces, and ¢oUaboratlve d18CU88lon8. To forge stronger Ilnk8 wlth natlon81 and r8glonal socletles of hyp8rt8nslon and r8L8t8d bodles, create wlder awareness of the So¢lety and to ¢ontlnue to dissemlnate Intorm8tlon regardlngthe 2020 ISH Glob81 Hypertgnslon Pr8Ctlce Guld611nes, the ISH work8- malnly vla Its six R8glon81 Advl80ry Groups IRAGs)- wlth 8fllllgted socletles end sends Teachlng Faculty, Councll mgmbgr8 or other members of th8 ISH188dershlp to p8rtlclp8tè in. and offer educatlon81 content at, numerous global a¢ilvltle8 each year. ISH representatlves presented at, and hold lolnt sesslons, at a great number of educ8tlonal and teachlng actlvltles and meetlngs In 2024 laddltlonal to the ISH2024 Sclentifl¢ Me8tln8 In C8rtagena, Colomb181 Includlng: AFRICA August: Southem Afrl¢8n Hyp8rtenslon Soclety Blennl81 Congre88 In Joh8nn88bur8. AMERICAS Aprll: Argentlno Soclety of HypertenBlon ISAHAI. ISH 8UPPOrted th8 new Investig8tor gW8rd8 presented on th18 occa810n. August: Brazlllan Soclety of Hypertenslon APAC F8bru8ry: Indono8lan Soclety of Hyperten$lon Iln6SHI June: Vletnamese Socletyof Hypertenslon (VSHI July.. M8L8yJl8n Soclety of Hypertenslon IMSHI October: Japanese Soclety of Hypert8n8lon IJSHI November: Korean Soclety of Hypertenslon IKSHI December: Chlnese Hypertenslon League ICHLI December: Hypertenslon Austr8118 EUROPE Aprfl: ISH Presldent 2022-2024 Bryan WIILlams 8nd Past Pre81dent M8cieJ Tom8SZ8wskl wer8 part of g 8rltlsh Heart Foundatlon18HF) weblnar explorlng rlsk8 assoclated wlth high blood pressure and how It can be man8ged. June.. European Society of Hypertenslon IESHI Meetlng ijolnt ISH-ESH Sesslon August: European So¢lety of C8rdlology IESCI l Jolnt ISH-ESC S8881on MENA March: ISH MENA Reglonal Advlsory Group Hypertenslon Symposlum June: ISH MENA Regional Athil80ry Group Hypertenslon Symposlum August: Iraqi Society of Hypertenslon December: ISH MENA Regional Advlsory Group Hypertenslon Symposlum SACA September: Paklstan Hypertenslon L88gu8 M8etlng TAR

Section D Achievernents Ilnd perlormc?nce The ISH was pleased to support the18unch of a n8w report at the EU P8rll8ment on 30 January to Improve adherence to hyperten81on treatment. The event was attended by ISH Past Pr88ident M8clel Tomaszewskl IUKI and ISH Councll member Claudio Borghl Iltaly). ISH contlnued to endorse the Certlflcat8 Hyperten81on Programme in Spanlsh organlsed by the Argentlne Soclety of Hypertenslon ISAHAI 8nd wlth signlllc8nt support given from the ISH Ameflc8s RAG. Thls comprehenslve program cons18ted ol 16 modules. fg8turlng both synchronous and asynchronous classes.11 Is designed for physl¢lan$ In the L8tln Amerlcan region aspiringto bacome hyportension experts. 90 Pgoplg 8radu8tgd from the 2-year C8rt1fic8t8 Course In 2024 from the second edltlon of th8 course. Work commenced by the ISH Atrlca RAG In 2024to creete a slmpllfled, unllled Afrlcan guideilne derlv8d from the ISH 2020 guldellnes and other locally avallable evidence, wbth the 81m of publlshlngthls In 2025. The Soclety addttlonally worked wlth th8 followlng global organlsatlons and hypertenslon related socletlgs to Bupport the followlng actlvltlé8: STRIDE BP e-learnlng plattomi: STRIDE 8P18 an Intern8tlonal 8clentlflc non-proflt org8nlzatlon that provldes guld8nce on the mathodology 8nd technologyfor accurate blood pressure evaluatlon. It18 offlclally supported byth8 ISH, tho European Soclety oIHypert8nslon, and the Wortd Hypertension League. tstsp&ll￿ Glob81 Coailtlon for Clrculatory H081th IGCCHI: GCCH brlngs together 32 Intarn8tlonal, reglon81 and natlonal 8takeholder8 In clrculatory health to drfve the urggllt g¢tlon ngaded to comb8t h98rt dl3e888 and 8trok8. Th8ir effort8 Includ publl8hlng posltlon paper8 and whlte papers. OMRON Ac8d8my: ISH contlnuéd to 8UPPOrt Omron Healthcare wlth thelr onllne currlculum on hyperten81on. OMRON Academy18 a currlculum framework made ty expert sclentlsts and offers contSnuous medlc81 educatlon for healthcare professlon818. The tralnlng highllght8 speclllc ch8118ng88 In the fleld of hypertenslon nd respiratory dlse8se and offers update8 on tha18te8t Édv8nc88 In th8s8 fi81d8. The onllne course8 8re d8v8lopèd for moblle and desktop use and the hypertgn8lon courses are endorsed bythe ISH, European Soclèty ol Hypert8nslon IESHI and the Britlsh 8nd Irlsh Hyperten3lon Soclety IBIHSI. After completlng each module, P8rt1clp8nts recelve 8 certlllcate of complètlon whlch c8n b8 used lor contlnulng medlc816ducatlon ICMEI credlts. LOo￿ngforWard to 2025: PL8n8 were advanced In 2024 to launch an ISH speclallsed educatlonal platlorm called ISH Ac8demy. The Academy ISH educatlonal pl8lfonn Is In thè proc￿3 of belng establlshed to provlde standardised. high-qu81ity content for ISH members. Thls wlll off8r a go to place for the hypertension community end educ8tlon81 pLattoim will discuss various aspects of hypertension. The aim is for accreditation to be offered so those completing the process wlll be recognised by their peers. Thè course wlll offer a curriculum and notjust a series ol presentstlons and be upd8ted on an ongoing basls to keep thls current. TAR 10

Section D Achievements and performance IENS.IDMBES.Eatio IEiiir.EEacIiyJTJES: New investigator Cornrnittee INICI The Society continued to encourage interaction and involvement with the ISH Nèw Invesligator Network on the Society website and via social media plattorms, F8¢ebook X and Linkedln. The Society circulated regular news via the main Society news channels to focus on the 8chievements of new researchers or clinical scientists undertaking a higher degree. To add to this, the spotlight section was retained on the Society webpages to feature hypertension future leaders. Mentorship and TrainingCommitte8 IMTCI The focus ol the Mentorship and Training Committèe in 2024 was to continue the successful ISH Mentorship Scheme. This is an exciting scheme designed to bring together new investigators (students and hypertension researchers who are within 10 years of 8 doctoral degree) and more experienced investigators. Womgn in Hypertension Research Committee ￿1HRCI The long-term goal of the Women in Hypertension Research Committee IWIHRCI is to address the barriers to progression that aff ect women and other under-represented groups within the society and to ensure equality of opportunity for all across the Society's activities and within the wider hypertension research community. With their activities the WIHRC are aiming to promote their mission. This is.. To promote women scientists and clinicians so that they can fulfil their career aspirations in hypertension and related CVD. To provide a plattorm for networking and mentoring To recognise and promote successes ofwomen in the hypertension community To encourage research in the field of 'hypertension and cardiovascular disease in wornen The spotlight section was retained on the Society webpages to provide an international platform to promote outstanding women working in hypertension research, learn about their scientific interestslachievements and to tell their person81 story. Capacity BuildingNetwork The ISH Capa¢ity Building Network IC8NI was lavnched on 27 November 2023 as a collaboration between the 3 ¢ommittees (ISH NIC, MTC and WIHRCI to off er career development and networking opportunities for early and mid-career researchers and those from under-represented backgrounds. The collaboration will strengthen the activities of each ol the committees and reduce duplication of effort. The 3 committees jointly organised activities in 2024- primarily at the ISH2024 Cartagena rneetinE- to help equip investigators with the skills they need to progress in research. See page 6. Whilst the focus of the CBN is on researchers in the earlier stages ol their careers, all members of the ISH are welcome to attend events. Extensive efforts were made in 2024 to increase the level and content of communication from the ISH to Society members and those non-ISH members engaged within the hypertension community. ISH magazine- Hypertension News- continued to be sent to stakeholders and made available on the open webpages. It is focused on scientific content and major updates and remains highly readable. Our members regularly express interest in communicating and exchanging their ideas via this publication. There were three issues in 2024. In addition, the monthly e-Bulletin for membership was expanded to match the increased activity within the Society and increased recognition of partner activity- Our magazine and bulletin are highly valued, with open rates for our email bulletins around 40-500/0. TAR

Sectlofl D Acliievemttnt5 and performance The Communicationsteam extensivelypromoted the ISH 2024 Cartagena. Colombia meetlng via a mixture of traditional le•mail, Hypertenslon New8. E-bulletinl and social media trwitter. Facebook. YouTube. Linkedln). All efforts were made and coordinated with the local organlslng committee. Other key activities in 2024 included supportlng the release of ISH posltlon p8pers, promotlng the ISH Colombia 2024 Sclentific Meeling 8nd ISH 2026 Dubai Meeting, as w811 a8 extensive Pfomotlon ofthe membership restructure and newfree memb8r8hip ¢8tegory op8n to anyone interested In high blood pressure. In 2024the ISH upgraded Its website to provide easier navigation and a higher quality browsing experignce for our members and vi8itors. The ISH Is also keeplng upto-date on modern communic8tion pr8¢tlces. ampioying us8 of video, and new social media platforms. For éxamplè, the Society is now on Instagram and Blues￿. This extends the reach and visibility of our cherltable activities. We also use our¢omms platfoms a5 a way of promotingthe work and activities of our 8ffili8ted national and regional societies around the world. Addltlonal new and ongolng p8rtnershlps V￿re establlshed and malntalned wlth the following organisations- 8P8rt from the ongoing relationship thatthe Society has with over 80 natlonal hypertenslon and cardiac socletles globally. European Society of Hypertenslon IESHI. Asian Pacific Society of Hypertension IAPSHI. L8tln-American Society of Hypertenslon. Endocrine Society, Resolve to Save Lives, KDIGO BP measurements standardization ¢onsen8US Partnership* C8rdiov8scu18rRes88rch. World Health Org8niz8tlon IWHOI. Framework Convention Alliance for Tobacco Control. Internatlon81 Alliance of Patients, Organizations. Intematlonal Council of Nurses. Intgrnational DiBbetes Federation, Intern8tlonalSoci8ty of N8phrolobry. Wortd Federatlon of Public Health Associations. World Heart Federation, Wortd Hypertension Le8gue (WHLI, World Organization of Family Doctors. World Stroke Organiz8tion. and Int8rnation81 Atherosclerosis Societyvia the Global Co81ition for Circulatory Health IGCCH) and HEARTS Initiative led bythe WHO. The ISH estsbli8h8d a flagship global progr8rnme through 8 new Pstient Guideline Inltiatlve, made possible by an Industry grant. This patient-focused guideline will provide people worldwide with the ess8ntialtools and knowledge requlred to effectlvely detect, monitor. and control their blood pr8ssure. The ISH changed its legal ststus to a Chafltsble Incorporatsd Org8ni8ation ICIOI and on 29 September 2023. the new CIO was entered on the Register of Charities wlth the registered Charity number 1204969. Assets were transferred from the Unincorporated Charity to the CIO on 2310 December 2024 and the Unlncorpor8ted Charity was closed, The CIO h8$ a new Constitution. and the aims and objectives are based on those of the Unincorporated Charity. TAR 12

Section E Financial review Brief statement of the charity's policy on reserves The financial position of the Society is Gonsidered by the Trustees to be in good order As shown by the financial statements. As the Society does not undertake fundraising from the general public and in view of the uncertainty of long-term support from the Biennial Scientific Heelings and Corporate Members, the Trustees h8ve approved a strategy to maintain the balance of the accounts to reasonable sum of at least-£500,000 to guarantee sustainable charitable activities in the event of unfavourable financial circumstances. The Society also wishes to contlnue Its policy of holding Biennial Scientific Meetings in regions of the world which on occasion, may not attract as much sponsorship as others and It is therefore important to maintain sufflclent reserves as indicated above to 8nsure existing commitments are met in the event that the 8iennial Scientific Meetings do not make a signiflcant surplus. This was notably the case for the Colombla 2024 Sclentlfie Meeting which was the first ISH meeting held in Latin Amerlca since 2004 and an Invaluable opportunity to better connect with the community in the region and expand the reach of the Society. Flnanclal Overvlgw lor 2024 Total Income for the year amounted to £318,008, representing an Increase ot £97,582 Compared lo 20231£220,4261. This increase is mainly attributable to a grant received 01 £1 OOK (equivalent to E86,684- ISH Empowerment 231241, which has been treated as restricted fund income. Direct ¢h8ritable expenditure in 2024 totalled £334,904, which Includes foreign exchange losses of É15,958. Charitable expenditure in 2023 totalled £304,798 Expendlture exceedgd income by £7 6,896, resulting in a net reduction in funds for the Society. This resulted In a tot81 lunds balance of £911,054 as of 31 December 2024, compared to £927,950 in 2023 New charitable expendltures have been commltted lor 2025, Includlng further educational activltles in the region5. It Is also th8 aim ol the Society to further build 115 research activities, and it is therefore import8nt to have suff ici8nt reserv85 to honour these longer-term research commitments. Further flnan¢ial rovlew detalls Iopllonal Inlormatlonl You may choose to include additional intormalion, where relevant about: The charity's principal sources of funds (including any fundraising). How expenditure has supported thekey objectives ol the charity. Investment policy and The Soclety's programme of 8du¢8tional activities is funded primarily in four ways.. 1. Royalties.. The Society receives 8 sm811 percentage of the revenue made by theJourn81 or Hypertension, the Society's official journal. 2. Corporate Members- The contributions made by approximately 5 commercl81 companies enable the Society to continue to develop existing initiatives and provide new educational resources and activities. Donations from our in(Justrial partners are received on the condition that all activities undertaken by Ihe Society are managed by the Trustees alone, 8nd that the Corporate Member5 are not involved with any decision-making. 3. Project and endorsement support.. Industry contributes project and endorsement support either to acknowledge ISH'S endorsement or to facilitate specific Society initiatives. 4. Biennial Scientific Meetings.. The Society receives a percentage of any surplus from these conferences. This amount can vary considerably each time, depending on how rnuch income TAR

objectives including any ethic81 investment policy adopted. is received from sponsorship and registration fees. 5. Membership subscription fees. Our overarching investment objective is to achieve a combination of sustainable growth and income. We aim to generate returns that allow us to fulfil our charilable purposes while carefully preserving the capital value of our portfolio. To manage liquidity and earn a return on short-terrn funds, a portion of our cash balances will be held on interest-be2ring deposit. RESPONSIBILITIES OFTHE TRUSTEES FOR THE FINANCIALSTATEMENTS The Trustees are responsible for preparing the report of the Trustees. and the financial statements in accordance with applicable law and regulations. The Trustee5 must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the charity of Ihe incoming resources and application of resources, including the income and expenditure, of the charity for that period. In preparing these financial statements. the Trustees are required to- select suitable accounting policie5 and then applythem consistently; observe the methods and principles in the Charities SORP; make judgments and estimates that are re8son8ble and prudent. state whether applicable UK accounting standards have been followed, subject to any material departures disclosed and explained in the financial statements- and prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charity will continue in business. The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the charity's transactions. disclose with reasonable accuracy at any time the linancial position of Ihe charity and enable them to ensure that the financial statements comply with the provisions of the charity's Constitution. They are also responsible for saleguarding the assets of the charity and hence lor taking ieasonable steps lor the prevention and detection of fraud and other ifregu18rities. Section F Other optional information Not applicable Section G Declaration Th8 trustees declare that they have approved the trustees, report above. Signed on behalf of the charity's tru5tee5 Signaturelsl Full namelsl Position leg secretaryp chair) Professor George Stergiou President Date 27th October 2025 TAR 14

IrfftRNATIONAL SOCfEfY OF HYPERTENSION REPORT OF THE TRusfEES- soaEfY INFORMATION FOR THE YEAR ENDED 310ECEMBER 2024 trLE5tee5 p￿ent thelr report wth the fir￿ndal ststements of the dwrity fty the yeor ended 31 December 2024. The tru*es have adopted the provlslons of Attounttng and Repjtlng by Charlves.. Statement of Recommended Prath appllcable to tha￿￿e$ prepartng thelr ￿Unts In accordan￿ wth the Anandal Reportong Standanl applicable in the UK ènd Republk of Ireland (FRS 102) (effecuve l January 2019). srRucfuRE. GOVERNANCE AND MANAGEMETtr Governlng document The charity Is govemed by its ulnsuts￿0n, Is a C￿rItable InC￿￿￿3￿j OrganisatbJn (ao). REFERENCE AND ADMINlSfRATIVE DEfAILS Registered Chartty number 1204969 Prlnclpal address clo Advènts Chartered Accountsnts 29 Gildredge Road BN214RU Professor M Tomaszew5ki {res￿ned 21.9.24) Professor F Charchar (reS￿ned 21.9.24) Professor D Prabhakardn (reslgned 21.9.24) Profe550r C Borghi (resfgned 21.9.24) Professor N Khan Ireslgned 21.9.24) Dr H Itoh Dr G Sterglou Professor M tho Professor U M SteckellNJs Professor B Imlllams Profe550r T Jafar Ass Prfw C A Romero ProfessiK K K Kariti Professor E S W Jones {aprdnted 21.9,24) Professor H Behelry (apwlrted 21.9.24) Profe550r D Colombarf lapkM)Inted 21.9.24) Profe55tsr J AristlzabakOcampD (arvjlnted 21.9.24) Professor Y ti {apFolnted 21.9.24) IndepeDdont Examlner Mr T Durrant Advanta artered Accountsnts 29 Glldredge Road E& Sussex BN214RU The detsiled trustees ryKJrt Is set out on pages TAR I to 14. Page I

INDEPENDENT EXAMINER'S REPORTTO THE TRUSTEES OF INTERNATIONAL SOCIETY OF HYPERTENSION Independent examlner's report to the trustees of Internatlonal Society of Hypertension I report to the charity trustees on my examination of the accounts of Interriational Society of Hypertenslon (the CIO) for the year ended 31 December 2024. This report is made solely to the trustees a5 a body, in accordance with the Charities Act 2011. My examination has been undertaken so that I mlght state to the trustees those matters l am required to state to them In an independent exarniner's report and for no other purpose. To the fullest extent perTllitted by law, I do not accept or assume responsibility to anyone other than the charity and the trustee5 a5 3 bodyi for my exarnination, for this report, or for the opinion5 1 have formed. Responslbilitles and basls of report As the charity trustees of the CIO you are responsible for the p￿paratIon of the accounts in accordance with the requirernents of the Charities Act 20111'the ACVI. I report in ￿$pert of my examination of the CIO'S accounts carried out under SeLtion 145 of the ALt and in carrying out my examination I have followed all applicable Directions given by the Charity Commission under Settion 14515llb) of the Art. Independent examlnerfs statement sin￿ your charity's gross income exceeded £250,000 your examiner rnust be a member of a listed body. I can confirm that l am qualified to undertake the examlnation because l am a member of the A550Ciation of Chartered Certified Accountants, which is one of the listed bodies. I have completed my examlnatlon. I conflrm th81 no material matters have come to my attentlon In connection with the examlnation glving me cause to believe that In any material respert.. ccounting records were not kept in respett of the CIO as requlred by Sectlon 130 of the Act,. or the accounts do not accord with those records., or the accounts do not cornply with the applicable requirements con￿MIng the form and content of accounts set oul in the Charities (Accounts and Reports) Regulation5 2008 other than any reqU1￿ment that the accounts glve a true and fair view whlch is not a matter considered as part of an independent examination. I have no concerns and have corne across no other rnatte￿ in connection wlth the examlnation to whlch attention should be drawn in this report in order to enable a proper Unde￿tandIng of the accounts to be reached, Mr T Durrant Advants Chartered Accountants 29 Glldredge Roèd Eastbourne East Sussex BN214RU Date.. 27 ¢)rtober 2025 Page 2

INTERNATIONAL SOCIETY OF HYPERTENSION srATEMENT OF FINANCIAL AcnvrriES FOR The YEAR ENDED 31 DECEMBER 2024 2024 Totsl funds 2023 Totsl fvnds Unrestricted Restrttted fvnd fund INCOME AND ENDOWMENYS FROM Donatlons and legacies 1,162 1,162 8,065 atltsble ath￿e$ Invesbment Incorne 225,318 86,684 312,iX12 210,888 Total 231325 220 426 EXPENDrnIRE ON Charitsble actlvltles CharftsNe acbvrbe5 307 817 Totsl 307 817 NEf INCOMEI{EXPENDrnIRE) (76,492) 59,597 (16,895) (84,372) RECONCILIATION OF FUNDS Totsl fvnd5 brought forward 927,950 927,950 1,012,322 TOTAL FUNDS CARRIED FORWARD 851458 911055 C014TINUING OPERATIONS All knctwne al￿ eyndSture has artsen frcwn continulng adNths. AJI comparatfve figures relate to tr£ old charlty. The fomi part ofthe5e finandal statements Page 3

31 DECEMBER2024 2023 Total furKIs fund fund fur¥Js Thnglble assets li 198 2,198 12 134,864 756 033 134,864 130,220 Cash at 890W7 59,597 1,084,443 CREDrroRS unts lalllro wRhln ¢)ne y¢Jr 13 (41,637) (41,637) {IS6,493) 908 851,458 911A155 927,950 NrfASSErs 851458 FUNDS Unrnstrtth funds Restrkted funds 14 851,458 927,950 TOTAL FUNDS st•l8 nts appTh&J by Ihe Bojrd d TTUSfte$ Ind thrthorw for on o%f.. and Igr•d on ks behaw ty: C A Rornero-Tri

INTERNATIONAL SOCIEfY OF HYPERTENSION NOTES TO THE FINANCIAL sfATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 ACCOUNTXNG POUaES Basls of preparlng the flnandal statements The financkl 51atsments of the dKrlty, whlch Is a publlc benefft enuty under FRS 102, have been prepared In ICCOTdano with the Charltles SORP {FRS 102) 'Aco)unting and Repo￿n9 by CharfUes', Statement of Recommended Prac0￿ ap￿kOble to charlttes preparlng thelr accoLsnts In accordance wth the Flnandal Repo￿n9 Stsndard applkable In the UK and Republlc of Ireland (FRS 102) (effethve l January 2019),, Ananclal Reporting Standard 102 The Flnandal Rewilng Stsndard applicable In the UK and Republlc of Ireland, and the Charltles Att 2011. Tr finandal ststements have been prepared under the hlstorh21 cost conventson. The finandal statsments are prepa￿d In Sterllngi Is the funcyonal currerKy of the ch. All the assets, Ilabllths, and aCb￿ of the intemavonal Sjdety of Ftypertenslon (UnIrK￿￿Orated cha￿ty reglstrntlon number 1122135) transferred from that to the ao unlntenupted a5 at 23 December 2024. The flnandal statements have prepared u51ng meryer accaundng. ￿1 comparatlve flgures relate to the old chartty. Golng concern At the tlme of apffing the finandal statsments, the Trustees have a reaFA)able expectsuon that the Intematlonal Wety of Hypertenslon has adequate resources to con￿n￿ In operdtlonal exISten￿ for the I0￿seeable f(rtu￿. Thus the Trustees condnue to adopt the golng concem bals of acoJunUng In weparlThJ the financlal statements. ZncDm• All Income 1$ recognlsed In tr Ststement of Flnandal AthI￿e5 orKe ￿ chartty hos enutlement to the funds, Is probable that the Snc(rfne wlll be recelved arKI the omunt can be mea￿red rellably. Cash donayons are recogntsed on recelpt. other donauons Jre recognlsed On￿ the Internawonal Sojety of Hypertenslon has teen nO￿tled of the donauon, unless perfornian￿ condlttons ￿￿lre defernl of the sum. Interest on funds held on depostt ts IrKluded when re￿(Vable and the amount can be MeaSu￿d rellth by the charlty. th1515 nomally nouficatton of the Interest patd or payable by the b)nk. Expndltur• Uabtifdes are recc¥nlsed as expendlture as soon as there ts a legal or construLthe obllgatlon ComM￿n9 the thartty to that expendltuye, It Is prnboble that a transfer of economlc benefits wlll be requlred In settlement and the amount of the obllgatlon can be measured rellably. eXpendItu￿ Is accounted for on an accruals basls and has been dasslfled under headlngs that aggregate all cost related to the category. Where costs cannot te dlrecty attrtbuted to pa￿CUlar headlngs they have been allcated to athvlttes ¢Jn a basls consLstert wth the u of Grants offertd subjert to Condl￿onS whth have not l)een met at the year er#1 date are noted as o commltsn￿t Ixrt not accrued as expendlture. Twnglble flxed ••8ots Depredatton Is provtded at the followlng annual rntes In ryder to wrfte off each asset over Its estlmated usefvl Fl>Xures and ffttlrrfJs Computer equlpment 33% on cost 33% on cost Taxatlon The charity Is exempt from CWFOra￿on tsx on ts tharftswe acuwues. Fund accountlng Unrestrlcte(I funds on be used In accordan￿ the charltsble obSethes at the dlscretlon of the trustees. Restrlcted fijnds can onty be used parucular restrtcted purposes wfthin tr objects of the charlty. Rethclors arf5e vthen 5￿fied by the donor or when funds are rdlseA for parttcular restrlcted purposes. Further explanatton of tre [wtU￿ and purpose of each fund15 Snduded In the notes to the llnandal ststements. Page 5 C0n￿nUed...

IIITeRNAT1014AL SOCIEfY OF HYPERTENSION IIOTES TO THE FINANCIAL STATEMENTS- eontlnu¢d FOR THE YEAR ENDED 31 DECEMBER 2024 ACCOUNTING POUCIES. conllnued Forelgn currenci•# A55ets and liabil￿eS In forelgn currencies are translated Intt> stsrflng at the rates of exchange rullng at the balan￿ sheet date. Transacttons In fOre￿n currendes are translated Into rling at ts Rte of exchange rullng at the dats of transacvon. Exchange dIfferen￿ are tsken Into accourt In arTlvlng at ts ¢werd￿n9 result. Penslon c4Mts other pogt-retlmment benefits The tharfty operate5 a defined cothbuuon penslorb xheme. ContrlLKth>ns payable to the chartys penslon stheme are charyed to the Ststern￿t of Rnandal AcVvMes In the pertod to whlth they relats. Flnandal 1MtNm￿tl The Internadonal Sodety of Hypertensl¢xs On￿ enters lrto baslc flnandal Instrument transad¢￿S that result In the recognthn of Anandal assets and l￿bI1rde$ Ilke trnde and other detrtors and ¢yedltors. Debt Ir￿me1￿ that a￿ poyable or ￿￿1va￿e wlthln one year, typkally trade debtors and credltors, are measured, Inldally and sUbseqUen￿y, at the undlscounted amount of the cash or other con4deraYon, expetted to be pald or recelved. FSnanthl assets that are measured at cost and amortlsed cost are assessed * the end of each repNOng perfod for obJe¢Uve eVIden￿ of ImpalmienL If objedve evidence of Impalment ts found, an Impalmient loss Is recognlsed In wofft and loss. For Ilnandal assets measured at c05L the Impalrment loss Is measured as the loss betrmn an asset carrytng value Jnd the present value of fu￿re cashflow dlscounted atthe assevs odglnal effethve lrterest rnte. Flnandal Ilabl1￿leS are derwntsed wln the thdty's contractual obllgatlons explre or are dlscharged or cancelled. CRfncAL ACCOUNTING JUDGEMENTS AND KEY SOURces OF EsfiMATION UNCERTAINTY In applICa￿an of the Intsmayonal Sodety of Hypertenslon's aCcoun￿ng pollctes, the Trustees a￿ requlred to make judgements, esymates and assUMp￿¢)nS of the carrylng amount of assets and Ilabllths that are not readlty apparent from other Sour￿5. the esilmates and a5sc(lated assumpUons a￿ based on hlstorfcal exF¢deft￿ and other faLtors censtdered to be relevant. ktual results may dlffer from these esdmate5. The ertlmatss ar￿ underfwng assumpY¢Jts are revlewed on an ongolng basls. Revlslons to accoUn￿n9 estlmates re recognlsed In the perfoj In whlch the esUmate15 revLfed where the revlslon affects onty that Fedod, or In the perk￿ of r￿SlOn arml firture pedod where the revlsEon effects ¢w￿nt and fvIu￿ pertojs. CHARrrABLe ACTIVMES 2024 2023 CorForate rnemtrorshlp fees Membetshlp fees Blennlal meetlng Joumal of Hypertenslon Royalde5 Pauent guldellne 1n6t1a￿ve ISH branded endotsements 61,817 15,852 19,936 104,8 67,423 13,310 1342) 106,671 31 Page 6 contlnued...

INTeRNATfoNAL SOaEfY OF HYPERTENSION NOTES TO THE FINANCIAL sfATEMEIITS- (Mllhyed FOR THE YEAR ENDEO 31 DECEMBER 2024 INVEsfMENT INCOME 2024 2023 Depos￿ account Interest Grnnt fundlng of acUvlVes Support costs (see note 6) Dlrect Totsls Charttabie actlvltles 156 482 Inltlthe and meeyng expertses are shown In fvll to provlde the fullest posslble InfomHUon. Durlng ts year IrKome of £19,936 {2023: £(3421) was re￿Ived from dor￿r5 and 5pon50f5 tt> (kfray those costs. SUPPORT cosrs Govemance Managemert Totsls Ch8rttble aCtIv￿eS arthble athltles. depredthi 146,086 9,296 155,382 Governance cots Incl￿les payments to the fimi that employs the Independent examlner of £5,000 (2023: £5,080) for Independent examlnayon fees and for the prepbrnkn of the annual flnandal statements to ctynply wlth the Charlttes Acts, aThl £1,711 (2023: £554) for other serv1￿. TRusfEIS' REMUNERATION AND BeNeFrrs None of the Trustees (or any persons connrfted vAth them) recew any remunernUon or benefits from the Interna￿ana[ Sodety of Hypertens1￿ durlrwj the year, EMPLOYEES The￿ w45 one (2023: one) employee durEng the yw. Page 7 c￿ttIn￿￿...

IIITERNAnONAL SOCZEfY OF HYPERTENSION NOTES TO THE FINANCIAL sfATEMENTS- (¥ntlnyed FOR THE YEAR ENDED 31 DECEMBER 2024 EXCEPTIONAL rrEMS Ex￿p￿onal thms Include fO￿Ign exchange I¢￿ In the sum of £15.958 (2023.. £411901. These Include unreallsed galns and losses arfslng as a result of revaluln9 fcrel9n exchange balan￿ uslrvj the rate prevalllng at the end of the finandal year. COMPARATIVES FOR THE STATEMEKf OF FINANCIAL AcfIvrnES Tctsl funds fvnd fund INCOME AND ENDOWME14TS FROM Ch)nattons and legaaes 0￿ritab￿ aCtiV￿e$ Investment Income 8,065 210,888 8,065 210,888 Total EXPENDITURE ON th)rftable atti¥itieg Charitsb￿ acti￿ties 126 086 Totsl NEf ZNCOMEIIEXPENDrnIRE) (84,3ni (84,372) RECONCILIATION OF FUNDS Totsl funds brought fornard 1,012,322 1,012,322 TOTAL FUNDS CARRIED FORWARD 927 950 11. TANGIBLE FIXED ASSErs F￿re$ and eqLdpment Ccrfnplrter equlpment Totals Additions DEPRECIATION arye for year 267 NET BOOK VALiIE At 31 December 2024 532 At 31 Decanber 2023 Page B ontinutyj...

NOTES TO THE FINANCIAL sfATEMeNTS. CQDthiued FOR THE YEAR ENDED 31 DECEMBER 2024 12. DEBTORS. AMOUIITS FALUNG DUE WITHIN OIIE YEAR 2024 2023 5,910 21,229 39 105,143 Other detrtors lal 5ecurbty & (ttr taxes 21,229 106,671 13. CREDrroRS: AMOUIITS FALUNG DUE WITIIIN ONE YEAR 2024 2023 Trade uedknrs Sodal seojrlty and other taxs 21,640 26,206 4,210 10,787 2,229 122,429 I& MOVEMElff IN FUNDS 1.1.24 fvnds 31.12.24 Unv••irfct•d fvnd• Genwjl fuKI 927,950 (76,492) 851,458 Re•trktsd fundi Patnt G￿delIne In 59,597 59,YJ7 TOTAL FUNDS Net movémert In fijnds, In tts abtht aR as frknth" In funds Generdl fund 231,324 (3)7￿16) (76,492) (27,088) 59,597 TOTAL FUNDS 318 crfflunued...

INTERNATIONAL SOCIEfY OF HYPERTENSION NOTES TO THE FXNANCIAL sfATEMErir5- contlnued FOR THE YEAR ENDED 31 DECEMBER 2024 I& MOVEMENT IN FUNDS- contlnued Comparatlves for movement In lund• Net rnovem￿t In funds At 1.1.23 31.12.23 Unrertrfctad funds Genernl fund 1,012,322 (84,3n) 927,950 TOTAL AINDS 1012 322 COmpara￿Ve net mOveM￿t In funds, Induded In the al￿ are Js fdlows: Incomlng Resources expended Movement In funds Unrq•trlrted fund• General fund 220,426 {304,798) (84,3n) TOTAL FUNDS A current year 12 monts and prtor year 12 months comblned pothon15 as folk>ws: Net movement In funds At 1.1.23 31.12.24 Unr••trlct•d fund¥ General fund 1,012,322 (160,864) 851,458 R••trlct•d fund• Pavent Guldellne Inthtlve 59,597 59,597 TOTAL FUNDS 1012 322 101267) 911055 A current year 12 months and prlor year 12 months com￿ned net movemert In fvnds, Induded In the above a as follows: InLvmlThJ Resour￿5 Movement In fijnds Unrestrlctad fund# General fvnd 451,750 (612,614) (160,864) R￿trItt￿ funds Pauent Guldeline Inidthe 86,685 (27,088) 59,597 TOTAL RINDS 639 702) 101267 Pdge 10 conun￿1...

INTERNATIONAL SOCIETY OF HYPERTENSION NOTES TO THE FINANCIAL sfATEMENTS- contlntrtd FOR THE YEAR ENDED 31 DECEMBER 2024 MOVEMENT IN FUNDS- tt•ntinued Purpose of restrkw fund The Patient Guldellne Initiative Fund was stsrted ty a grant of £86,684 gfvi to the tharfty to create a new fiagshlp gbbal wogramme ￿SH Ernpowert. Thts 15 a pthnt ￿ntred guklellne to emF&v￿r W*nts to bthr detec¢ mon¢tor and control thelr blood pressu￿. The resttItt￿ fund wa5 trdnsferred to the CIO and any rethcUon5 In tKeserved. I& RELATED PARTYTRANSAcfioNS No key management personnel rece￿ any remuneratk>n In tr￿ thrrent or p￿or year. During the year the Intemational SOC￿ of Hypertension entered Intrj the follothng trar￿￿On$ wlth S(￿ of Its trustees, in respect of travel an(J accomrnc#Jalion expenses relmtyjrsed In the sum of £101,662 (2023: £94.644}. The number 0ftr￿ so reimbursed was 11 (2023: 12). Page 11